» Articles » PMID: 39771001

Development and Pragmatic Randomized Controlled Trial of Healthy Ketogenic Diet Versus Energy-Restricted Diet on Weight Loss in Adults with Obesity

Overview
Journal Nutrients
Date 2025 Jan 8
PMID 39771001
Authors
Affiliations
Soon will be listed here.
Abstract

: The ketogenic diet (KD) is widely used for weight management by reducing appetite, enhancing fat oxidation, and facilitating weight loss. However, the high content of total and saturated fats in a conventional KD may elevate low-density lipoprotein (LDL)-cholesterol levels, a known risk factor for cardiovascular diseases, highlighting the need for healthier alternatives. This study aimed to investigate the effect of a newly developed Healthy Ketogenic Diet (HKD) versus an Energy-Restricted Diet (ERD) on weight loss and metabolic outcomes among adults with obesity. : Multi-ethnic Asian adults ( = 80) with body mass index ≥ 27.5 kg/m were randomized either to HKD ( = 41) or ERD = 39) for 6 months. Both groups followed an energy-restricted healthy diet, emphasizing on reducing saturated and trans fats. The HKD group additionally limited net carbohydrate intake to no more than 50 g per day. Dietary adherence was supported via the Nutritionist Buddy app with dietitian coaching. The primary outcome was weight change from baseline at 6 months. Secondary outcomes included weight change at 3 months and 1 year, along with changes in metabolic profiles. Data were analyzed using linear regression with an intention-to-treat approach. : The HKD group achieved significantly greater mean weight loss at 6 months than the ERD group (-7.8 ± 5.2 kg vs. -4.2 ± 5.6 kg, = 0.01). The mean weight loss percentage at 6 months was 9.3 ± 5.9% and 4.9 ± 5.8% for the HKD and ERD groups, respectively ( = 0.004). Improvements in metabolic profiles were also significantly better in the HKD group [glycated hemoglobin (-0.3 ± 0.3% vs. -0.1 ± 0.2%, = 0.008), systolic blood pressure (-7.7 ± 8.9 mmHg vs. -2.6 ± 12.2 mmHg, = 0.005), and aspartate transaminase (-7.6 ± 15.5 IU/L vs. 0.6 ± 11.5 IU/L, = 0.01)], with no increase in LDL-cholesterol (-0.12 ± 0.60 mmol/L vs. -0.04 ± 0.56 mmol/L, = 0.97) observed in either group. : The HKD was more effective than the ERD in promoting weight loss and improving cardiometabolic outcomes without elevation in LDL-cholesterol. It can be recommended for therapeutic intervention in patients with obesity.

References
1.
Bueno N, de Melo I, de Oliveira S, Ataide T . Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013; 110(7):1178-87. DOI: 10.1017/S0007114513000548. View

2.
Lim S, Ong K, Johal J, Han C, Yap Q, Chan Y . Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2021; 4(6):e2112417. PMC: 8176331. DOI: 10.1001/jamanetworkopen.2021.12417. View

3.
Shai I, Schwarzfuchs D, Henkin Y, Shahar D, Witkow S, Greenberg I . Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008; 359(3):229-41. DOI: 10.1056/NEJMoa0708681. View

4.
Sumithran P, Prendergast L, Delbridge E, Purcell K, Shulkes A, Kriketos A . Ketosis and appetite-mediating nutrients and hormones after weight loss. Eur J Clin Nutr. 2013; 67(7):759-64. DOI: 10.1038/ejcn.2013.90. View

5.
Gjuladin-Hellon T, Davies I, Penson P, Amiri Baghbadorani R . Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis. Nutr Rev. 2018; 77(3):161-180. DOI: 10.1093/nutrit/nuy049. View